121 related articles for article (PubMed ID: 9324166)
1. Uncertainty in liver function assessment on the basis of single-point galactose concentration.
Fabbri A; Bianchi G; Brizi M; Zoli M; Marchesini G
Digestion; 1997; 58(4):379-83. PubMed ID: 9324166
[TBL] [Abstract][Full Text] [Related]
2. The quantitative liver function as measured by the galactose elimination capacity. I. Diagnostic value and relations to clinical, biochemical, and histological findings in patients with steatosis and patients with cirrhosis.
Lindskov J
Acta Med Scand; 1982; 212(5):295-302. PubMed ID: 7180579
[TBL] [Abstract][Full Text] [Related]
3. Assessment of liver function using a novel galactose single point method.
Tang HS; Hu OY
Digestion; 1992; 52(3-4):222-31. PubMed ID: 1334011
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the deterioration rates of liver function in cirrhosis, based on galactose elimination capacity.
Marchesini G; Fabbri A; Bugianesi E; Bianchi GP; Marchi E; Zoli M; Pisi E
Liver; 1990 Apr; 10(2):65-71. PubMed ID: 2352456
[TBL] [Abstract][Full Text] [Related]
5. The quantitative liver function as measured by the galactose elimination capacity. II. Prognostic value and changes during disease in patients with cirrhosis.
Lindskov J
Acta Med Scand; 1982; 212(5):303-8. PubMed ID: 7180580
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of quantitative liver function tests in viral cirrhosis: a prospective study.
Addario L; Scaglione G; Tritto G; Di Costanzo GG; De Luca M; Lampasi F; Galeota Lanza A; Picciotto FP; Tartaglione MT; Utech W; Macr M; Giannelli E; Ascione A
Eur J Gastroenterol Hepatol; 2006 Jul; 18(7):713-20. PubMed ID: 16772827
[TBL] [Abstract][Full Text] [Related]
7. Quantitative liver function tests as surrogate markers for end-points in controlled clinical trials: a retrospective feasibility study.
Lotterer E; Högel J; Gaus W; Fleig WE; Bircher J
Hepatology; 1997 Dec; 26(6):1426-33. PubMed ID: 9397982
[TBL] [Abstract][Full Text] [Related]
8. Age-dependency of galactose elimination capacity in healthy children and children with chronic liver disease.
Lange A; Grønbæk H; Vilstrup H; Keiding S
Scand J Gastroenterol; 2011 Feb; 46(2):197-200. PubMed ID: 21034348
[TBL] [Abstract][Full Text] [Related]
9. Novel galactose single point method as a measure of residual liver function: example of cefoperazone kinetics in patients with liver cirrhosis.
Hu OY; Tang HS; Chang CL
J Clin Pharmacol; 1995 Mar; 35(3):250-8. PubMed ID: 7608313
[TBL] [Abstract][Full Text] [Related]
10. A simplified method to determine galactose elimination capacity in patients with liver disease.
Bergström M; Söderman C; Eriksson LS
Scand J Clin Lab Invest; 1993 Nov; 53(7):667-70. PubMed ID: 8272755
[TBL] [Abstract][Full Text] [Related]
11. Effects of hyperglycemia on quantitative liver functions by the galactose load test in diabetic rats.
Young TH; Tang HS; Lee HS; Hsiong CH; Hu OY
Metabolism; 2007 Sep; 56(9):1265-9. PubMed ID: 17697871
[TBL] [Abstract][Full Text] [Related]
12. [The oral galactose tolerance as a liver function test. Clinical-experimental studieson the prolem of dosage].
Rommel K; Grimmel K
Med Klin; 1967 Feb; 62(5):168-71. PubMed ID: 5590185
[No Abstract] [Full Text] [Related]
13. Use of quantitative liver function tests--caffeine clearance and galactose elimination capacity--after orthotopic liver transplantation.
Nagel RA; Dirix LY; Hayllar KM; Preisig R; Tredger JM; Williams R
J Hepatol; 1990 Mar; 10(2):149-57. PubMed ID: 2332584
[TBL] [Abstract][Full Text] [Related]
14. The galactose elimination capacity and mortality in 781 Danish patients with newly-diagnosed liver cirrhosis: a cohort study.
Jepsen P; Vilstrup H; Ott P; Keiding S; Andersen PK; Tygstrup N
BMC Gastroenterol; 2009 Jun; 9():50. PubMed ID: 19566919
[TBL] [Abstract][Full Text] [Related]
15. [The galactose breath test. Modification of the method and comparison with galactose elimination capacity and plasma disappearance of bromsulphatein (author's transl)].
Grimm L; Bircher J; Preisig R
Z Gastroenterol; 1980 Jan; 18(1):45-56. PubMed ID: 7385933
[TBL] [Abstract][Full Text] [Related]
16. [The prognostic value of the serial determination of galactose elimination capacity in chronic active hepatitis].
Aebli N; Reichen J
Schweiz Med Wochenschr; 1991 Jun; 121(26):970-6. PubMed ID: 1862313
[TBL] [Abstract][Full Text] [Related]
17. The galactose elimination capacity test: a study of the technique based on the analysis of 868 measurements.
Fabbri A; Bianchi G; Motta E; Brizi M; Zoli M; Marchesini G
Am J Gastroenterol; 1996 May; 91(5):991-6. PubMed ID: 8633594
[TBL] [Abstract][Full Text] [Related]
18. Value of prealbumin plasma levels as liver test.
Rondana M; Milani L; Merkel C; Caregaro L; Gatta A
Digestion; 1987; 37(2):72-8. PubMed ID: 3622940
[TBL] [Abstract][Full Text] [Related]
19. [Liver function tests in a clinical comparison].
Stremmel W; Wojdat R; Groteguth R; Zoedler M; Ebener T; Niederau C; Becker H; Strohmeyer G
Z Gastroenterol; 1992 Nov; 30(11):784-90. PubMed ID: 1471385
[TBL] [Abstract][Full Text] [Related]
20. Galactose elimination capacity as a prognostic marker in patients with severe acetaminophen-induced hepatotoxicity: 10 years' experience.
Schmidt LE; Ott P; Tygstrup N
Clin Gastroenterol Hepatol; 2004 May; 2(5):418-24. PubMed ID: 15118981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
